This inventor holds 2 USPTO granted patents. Top assignee: Sangamo Therapeutics, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Innovations by Inventor Kyle McGovern
Introduction
Kyle McGovern is an accomplished inventor based in Richmond, CA. She has made significant contributions to the field of gene therapy through her innovative work. Her expertise lies in developing methods and compositions that enhance the capabilities of adeno-associated virus (AAV) capsids.
Latest Patents
Kyle holds a patent for her invention titled "Engineering AAV." This patent provides methods and compositions to develop AAV capsids with desired characteristics compared to natural AAV serotypes. These engineered capsids are particularly useful for delivering genome engineering molecules and gene therapy molecules, offering potential treatments for subjects in need.
Career Highlights
Kyle McGovern is currently employed at Sangamo Therapeutics, Inc., where she continues to advance her research in gene therapy. Her work has positioned her as a key figure in the development of innovative therapeutic solutions.
Collaborations
Kyle collaborates with various professionals in her field, including her coworker David S Ojala, who contributes to their shared goals in advancing gene therapy technologies.
Conclusion
Kyle McGovern's contributions to the field of gene therapy through her innovative patent and work at Sangamo Therapeutics, Inc. highlight her role as a leading inventor in this important area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile